ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

ANI Pharmaceuticals will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 12:30 PM ET. CEO Nikhil Lalwani and CFO Stephen Carey will represent the company during the event. A webcast of the presentation will be accessible on the company’s website in the Investors section. Additionally, ANI will hold 1x1 meetings on the same day, which can be requested through H.C. Wainwright. ANI Pharmaceuticals focuses on developing high-quality branded and generic pharmaceutical products.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 24^th Annual Global Investment Conference as follows:

Date:						Monday, September 12, 2022
Time:						12:30PM ET
Webcast:						Click Here

The webcast will be accessible via the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.

ANI will be participating in 1x1 meetings on September 12. Meetings can be requested via H.C. Wainwright.

About ANI

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin^® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005310/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Media:

Faith Pomeroy-Ward, ANI Pharmaceuticals, Inc.

T: 817-807-8044

E: Faith.pomeroyward@anipharmaceuticals.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When is ANI Pharmaceuticals presenting at the H.C. Wainwright Conference?

ANI Pharmaceuticals will present on September 12, 2022, at 12:30 PM ET.

Who will represent ANI Pharmaceuticals at the conference?

CEO Nikhil Lalwani and CFO Stephen Carey will represent ANI Pharmaceuticals.

How can I access the ANI Pharmaceuticals presentation webcast?

The webcast can be accessed via the ANI Pharmaceuticals website under the Investors section.

What is the focus of ANI Pharmaceuticals?

ANI Pharmaceuticals focuses on developing, manufacturing, and marketing branded and generic prescription pharmaceutical products.

Are there 1x1 meetings available with ANI Pharmaceuticals?

Yes, ANI will be participating in 1x1 meetings on September 12, 2022, which can be requested through H.C. Wainwright.